# TREGZI

NDC: 85866-223
Generic name: allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq
Labeler / Manufacturer: Orca Biosystems Inc.
Product type: CELLULAR THERAPY
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20260630

FDA application: BLA125868

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"85866-223"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=85866-223
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2157e11b-87c3-4d54-a225-81b341e4e21a